Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing desensitization treatments to protect people with food allergies from the life-threatening consequences of accidental exposures to their allergens. We are currently conducting a Phase 3 study of our lead product, AR101 for the treatment of peanut allergy.
Type
Public
HQ
Brisbane, US
Founded
2011
Size (employees)
62 (est)+15%
Aimmune Therapeutics was founded in 2011 and is headquartered in Brisbane, US

Aimmune Therapeutics Office Locations

Aimmune Therapeutics has an office in Brisbane
Brisbane, US (HQ)
300 8000 Marina Blvd

Aimmune Therapeutics Data and Metrics

Aimmune Therapeutics Financial Metrics

$, USD

Net income (FY, 2016)

(80.8 m)

EBIT (FY, 2016)

(81.5 b)

Market capitalization (22-Jun-2017)

1 b

Closing share price (22-Jun-2017)

19.2

Cash (31-Dec-2016)

124 m
Aimmune Therapeutics's current market capitalization is $1 b.
$, USDFY, 2015FY, 2016

R&D expense

19.8 m54.6 b

General and administrative expense

16.2 m26.9 b

Operating expense total

36 m81.5 b

EBIT

(36 m)(81.5 b)

Interest expense

(36 k)

Interest income

217 k

Pre tax profit

(35.8 m)(80.8 b)

Net Income

(35.8 m)(80.8 m)
$, USDFY, 2015FY, 2016

Cash

76.7 m124 m

Inventories

5.6 m2.7 m

Current Assets

197.5 m251.7 m

PP&E

2.7 m10.4 m

Total Assets

212.4 m298.8 m

Accounts Payable

1.9 m1.4 m

Current Liabilities

5.1 m11.5 m

Additional Paid-in Capital

259.7 m420.2 m

Retained Earnings

(53.3 m)(134.2 m)

Total Equity

206.3 m286 m

Financial Leverage

1 x1 x
$, USDFY, 2015FY, 2016

Net Income

(35.8 m)(80.8 m)

Depreciation and Amortization

115 k534 k

Inventories

4 m

Accounts Payable

1.1 m(994 k)

Cash From Operating Activities

(35.7 m)(56.6 m)

Purchases of PP&E

(1.7 m)(7.7 m)

Cash From Investing Activities

(125.2 m)(43.9 m)

Cash From Financing Activities

235.3 m147.8 m
Y, 2016

Financial Leverage

1 x

Aimmune Therapeutics Operating Metrics

FY, 2016

Patents Issued

2

Aimmune Therapeutics Market Value History

Aimmune Therapeutics Online and Social Media Presence

Aimmune Therapeutics Company Life and Culture

You may also be interested in